Drug intelligence / Profile preview

Pudilan Xiaoyan

Development stage
Phase 4
Lead developer
China Academy of Chinese Medical Sciences
Modality
Small Molecules
Administration
Oral
01

Overview

Pudilan Xiaoyan is a proprietary traditional Chinese medicine (TCM) formulation widely used in China for its anti-inflammatory and detoxifying properties. It is most commonly available as an oral liquid (Pudilan Xiaoyan Oral Liquid) or as tablets. The formula contains multiple herbal ingredients including Scutellaria baicalensis (Huang Qin), Taraxacum mongolicum (Dandelion), Isatis indigotica root (Radix Isatidis), and Corydalis bungeana. Its primary indications are the treatment of inflammatory conditions such as upper respiratory tract infections, pharyngitis, tonsillitis, mumps in children, and viral pneumonia. Mechanistically, it acts by reducing nitroxidative stress and blocking TLR4 activation along with NF-κB phosphorylation—key pathways involved in inflammation. Network pharmacology studies suggest that its active components target multiple inflammatory mediators and immune pathways[1][2][5][10]. It is included in the Chinese Pharmacopoeia and recommended by various health authorities for use against certain viral infections such as H1N1 influenza and hand-foot-and-mouth disease[2].

Brand names
Pudilan Xiaoyan Oral LiquidPudilan Anti-Inflammatory TabletsPudilan Xiaoyan Pian
Other names
PDLPu Di Lan Xiao Yan
02

Targets

RELA (Nuclear Factor Kappa B Subunit p65)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Pudilan Xiaoyan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pudilan Xiaoyan.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call